Aug 27 (Reuters) - Teva Pharmaceutical Industries (NYSE:TEVA) Ltd TEVA.TA :
* Canada announces the launch of (pr)Teva-solifenacin, a generic of
(pr)vesicare
* Canada limited - announced health Canada's approval of its application for
the generic version of (pr)vesicare
* Canada limited - (pr)Teva-solifenacin is available immediately in pharmacies
across Canada
* Source text for Eikon ID:nCNW2LrXKa
* Further company coverage TEVA.TA